¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"Core Binding Factor alpha Subunits"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
androgen binding protein
¾Èµå·Î°Õ°áÇմܹéÁú
binding
1. ¹À½ 2. °áÇÕ
binding energy
°áÇÕ¿¡³ÊÁö
binding orbit
°áÇձ˵µ
binding site
°áÇÕºÎÀ§
competitive binding assay
°æÀïÀû°áÇպм®
competitive protein binding radioassay
°æÇմܹéÁú°áÇÕ¹æ»çÃøÁ¤(¹ý)
corticosteroid-binding globulin
ÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀ̵å°áÇձ۷κҸ°
cortisol-binding globulin
ÄÚÆ¼¼Ö°áÇձ۷κҸ°
gonadal steroid-binding globulin
»ý½Ä»ù½ºÅ×·ÎÀ̵å°áÇձ۷κҸ°
iron binding protein
ö°áÇմܹéÁú
iron-binding capacity
ö°áÇÕ´É
ligand binding site
¸®°£µå°áÇÕºÎÀ§
olfactory binding protein
Èİ¢°áÇմܹéÁú
orthodontic binding wire
±³Á¤¿ë¹±âö»ç, ±³Á¤¿ë°áÂû¼±
ÀÌÀü
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
2
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
transforming growth factor
Àüȯ¼ºÀåÀÎÀÚ
vascular endothelial growth factor
Ç÷°ü³»ÇǼºÀåÀÎÀÚ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
binding site
°áÇÕºÎÀ§
protein binding
´Ü¹é°áÇÕ
receptor binding
¼ö¿ëü°áÇÕ
cross-binding
±³Â÷¿¬°á
competitive protein binding radioassay
°æÇմܹé°áÇÕ¹æ»çÃøÁ¤(¹ý)
corticosteroid-binding globulin
ÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀ̵å°áÇձ۷κҸ°
cortisol-binding globulin
ÄÚ¸£Æ¼¼Ö°áÇÕ±Û·Îºí¸°
iron-binding capacity
ö°áÇÕ´É
gonadal steroid-binding globulin
»ý½Ä»ù½ºÅ×·ÎÀ̵å°áÇձ۷κҸ°
sex hormone-binding globulin
¼ºÈ£¸£¸ó°áÇÕ±Û·Îºí¸°
testosterone-binding globulin
Å×½ºÅ佺Å׷аáÇձ۷κҸ°
thyroxine-binding globulin
Ƽ·Ï½Å°áÇÕ±Û·Îºí¸°
iron binding protein
ö°áÇմܹéÁú
olfactory binding protein
Èİ¢°áÇմܹé
orthodontic binding wire
±³Á¤¿ë¹±âö»ç, ±³Á¤¿ë°áÂû¼±
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
receptor binding
¼ö¿ëü°áÇÕ
17-alpha-hydroxycorticosteroid
17-¾ËÆÄ-È÷µå·Ï½ÃÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀ̵å
17-alpha-hydroxyprogesterone
17-¾ËÆÄ-È÷µå·Ï½ÃÇÁ·Î°Ô½ºÅ×·Ð
alpha behavior
¾ËÆÄÇàÀ§
alpha blocking
¾ËÆÄÂ÷´Ü
alpha cell
¾ËÆÄ¼¼Æ÷
alpha cell
¾ËÆÄ¼¼Æ÷(¡á¬øà)
alpha cell glucagon cell
¾ËÆÄ¼¼Æ÷ ±Û·çÄ«°ï¼¼Æ÷
alpha cell tumor
¾ËÆÄ ¼¼Æ÷Á¾(¡á¬øàðþ)
alpha chain disease
¾ËÆÄ¼âº´(¡áðÜ»).
alpha chain disease
¾ËÆÄ¼âÁúȯ
alpha cradle
¾ËÆÄ¹Þħ´ë
alpha decay
¾ËÆÄºØ±«
alpha emitter
¾ËÆÄ¹æ»çü, ¾ËÆÄ¹æÃâü
alpha fetoprotein =AFP
¾ËÆÄžƴܹé(¡÷Ãä®Ó±ÛÜ).
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
binding
°áÇÕ(Ì¿ùê)
binding
¹À½, °áÇÕ.
binding activity
°áÇÕȰ¼º(Ì¿ùêüÀàõ).
binding activity
¸é¿ª°áÇÕȰ¼º(Ì¿ùêüÀàõ).
binding affinity
°áÇÕģȼº(Ì¿ùêöÑûúàõ)
binding displacement analysis
°áÇÕº¯À§ºÐ¼®(Ì¿ùêܨêÈÝÂà°).
binding energy
°áÇÕ¿¡³ÊÁö
binding energy
°áÇÕ(Ì¿ùê)¿¡³ÊÁö
binding orbit
°áÇձ˵µ(Ì¿ùêÏùÔ³).
binding site
°áÇÕºÎÀ§.
binding site
°á ÇÕºÎÀ§.
calcium-binding protein
Ä®½· °áÇմܹé(Ì¿ùêÓ±ÛÜ)
cap binding protein
ĸ°áÇմܹéÁú
cell growth,ligand receptor binding
¸®°£µå¼ö¿ë±â°áÇÕ (¡áôé»ÐïÌ¿ùê)
cellular retinol-binding protein
¼¼Æ÷³» ·¹Æ¼³î °áÇմܹé
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½